5:40 p.m.
One Merck & Co.'s facility located in Durham is at the receiving end of a
$105.4 million federal government investment to aid in the production of the Johnson & Johnson COVID-19 vaccine.
"Our Durham, N.C. facility is part of Merck's global manufacturing network. This site is preparing to produce bulk drug substance for the J&J vaccine," a spokesperson for the company said in a statement to ABC11.
JUST IN: Durham’s Merck Vaccine Plant will aid in production of the Johnson & Johnson COVID-19 vaccine. The partnership between the two pharmaceutical competitors was formally announced at a White House news conference with President Biden and the CEO’s of Merck and J&J.#abc11pic.twitter.com/Tc5WxDRAry— Joel Brown (@JoelBrownABC11) March 10, 2021